Black Rock Inc. Sensei Biotherapeutics, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Sensei Biotherapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 33,582 shares of SNSE stock, worth $24,850. This represents 0.0% of its overall portfolio holdings.

Number of Shares

33,582

Previous 34,813 3.54%

Holding current value

$24,850

Previous $24,000 45.83%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$0.73 - $1.17 $898 - $1,440	-1,231 Reduced 3.54%	33,582 $35,000
Q4 2023 Feb 13, 2024	SELL	$0.53 - $0.82 $218 - $337	-412 Reduced 1.17%	34,813 $24,000
Q3 2023 Nov 13, 2023	SELL	$0.75 - $1.32 $1,081 - $1,903	-1,442 Reduced 3.93%	35,225 $28,000
Q2 2023 Aug 11, 2023	SELL	$1.14 - $1.81 $1,643 - $2,610	-1,442 Reduced 3.78%	36,667 $41,000
Q1 2023 May 12, 2023	BUY	$1.31 - $1.7 $1,619 - $2,101	1,236 Added 3.35%	38,109 $57,000

Q4 2022 Feb 13, 2023	SELL	$1.33 - $1.74 $182,312 - $238,513	-137,077 Reduced 78.8%	36,873 $54,000
Q3 2022 Nov 14, 2022	SELL	$1.7 - $2.24 $8,404 - $11,074	-4,944 Reduced 2.76%	173,950 $270,000
Q2 2022 Aug 12, 2022	SELL	$1.49 - $2.3 $1.47 Million - $2.27 Million	-989,117 Reduced 84.68%	178,894 $406,000
Q1 2022 May 12, 2022	SELL	$2.22 - $6.07 $77,073 - $210,738	-34,718 Reduced 2.89%	1,168,011 $2.7 Million
Q4 2021 Feb 10, 2022	BUY	$4.85 - $10.48 $981,673 - $2.12 Million	202,407 Added 20.23%	1,202,729 $6.98 Million
Q3 2021 Nov 09, 2021	BUY	$6.89 - $11.99 $4.39 Million - $7.64 Million	636,856 Added 175.22%	1,000,322 $10.5 Million
Q2 2021 Aug 11, 2021	BUY	$9.1 - $15.14 $3.31 Million - $5.5 Million	363,466 New	363,466 $3.55 Million

Others Institutions Holding SNSE

# of Institutions

Shares Held

2.32M

Call Options Held

Put Options Held

View Full List

About Sensei Biotherapeutics, Inc.

Ticker SNSE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,720,300
Market Cap $22.7M
Description
Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune res...

More about SNSE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account